The FDA says it will authorize Pfizer's COVID-19 vaccine, paving the way for people in the US to start getting shots as early as Monday The Food and Drug Administration said Friday that it would "rapidly work toward" issuing an emergency-use authorization for Pfizer and BioNTech's coronavirus vaccine.

entrepreneur daily

This story originally appeared on Business Insider

Pete Marovich | Getty Images via Business Insider
US Health and Human Services Secretary Alex Azar.

The US Food and Drug Administration has said it intends to authorize Pfizer and BioNTech's COVID-19 vaccine.

It said Friday morning that it would "rapidly work toward finalization and issuance of an emergency-use authorization" for the shot. The COVID-19 vaccine would be the first to be authorized for use in the US.

The FDA said it had notified the drugmakers as well as the Centers for Disease Control and Prevention and the federal vaccine initiative known as Operation Warp Speed so they could "execute their plans for timely vaccine distribution."

Related: 9 Ways to Support Your Local Economy During a Crisis

The vaccine could be rolled out as early as Monday, Health and Human Services Secretary Alex Azar said on "Good Morning America" on Friday morning.

"We could be seeing people getting vaccinated Monday, Tuesday of next week," Azar said.

The announcement follows an endorsement from an independent expert panel of more than 20 leading scientists and doctors, who reviewed data from a trial of Pfizer and BioNTech's vaccine on Thursday.

Operation Warp Speed leaders have previously said the plan is to ship 2.9 million doses of the vaccine within days.

The US hopes to vaccinate 100 million people by March: 20 million in December, 30 million in January, and 50 million more in February. Those projections depend on getting vaccines from Pfizer and from Moderna, a biotech company that also has a highly effective shot under FDA review.

Federal authorities are allocating vaccine doses to states and territories based on their adult populations, and each state will decide how to divvy up its supply. Earlier this month, a CDC advisory group recommended that healthcare workers and nursing-home residents be at the front of the line.

But a key COVID-19 advisor to President-elect Joe Biden has warned Americans to expect "hitches" in the rollout of Pfizer and BioNTech's vaccine.

"The biggest challenge is going to be both production and then getting it into people's arms," Dr. Atul Gawande said Thursday.

The UK began administering Pfizer and BioNTech's vaccine on Tuesday, making it the first nation in the West to roll out a COVID-19 vaccine. The next day, Canada became the second Western country to authorize the vaccine.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Side Hustle

I Started a Semi-Passive Side Hustle That Earns $33,000 a Week on Amazon: 'Selling There Is a No-Brainer'

Dr. Jenny Woo wanted to create a product that would help people connect, and it turned out to be a lucrative one.

Business News

Compass Agrees to Pay $57.5 Million to Settle Real Estate Commissions Lawsuits

The class action lawsuits accused Compass of violating antitrust law and conspiring to overcharge U.S. home sellers.

Business News

Jerry Seinfeld Is Now Reportedly a Billionaire — Here's Where His Wealth Comes From

Seinfeld also boasts an impressive real estate portfolio.

Business News

X Is Losing Users and Struggling to Attract Creators, According to New Data

The company, which is owned by Elon Musk, says that 1.7 million people join the platform every day.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.